Kenvue (KVUE) M&A Announcement summary

Deal rationale and strategic fit

• The merger creates a $32 billion global health and wellness leader with complementary portfolios, 10 billion-dollar brands, and global reach, serving nearly half the global population.

• Strategic focus is on health and wellness, leveraging demographic tailwinds, innovation, and consumer prioritization of wellness.

• Both companies share purpose-led, performance-driven cultures and a commitment to science-backed innovation and efficiency.

• The deal builds on transformation initiatives and long-term strategies to shift toward higher growth, higher margin categories.

• The combination enables comprehensive everyday care across all life stages, enhancing consumer lifetime value and category leadership.

Financial terms and conditions

• The target is valued at an enterprise value of $48.7 billion, with a headline multiple of 14.3x LTM Adjusted EBITDA and an effective multiple of 8.8x post-synergies.

• Kenvue shareholders receive $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share, totaling $21.01 per share.

• Post-merger, Kimberly-Clark shareholders will own about 54% and Kenvue shareholders about 46% of the combined company.

• More than 80% of consideration is in stock, supporting a strong balance sheet; cash funded by balance sheet, new debt, and asset sale proceeds.

• The transaction is expected to close in the second half of 2026, pending shareholder and regulatory approvals.

Synergies and expected cost savings

• Total expected synergies are $2.1 billion in EBITDA, with $1.9 billion from cost savings and $500 million from revenue synergies, net of $300 million reinvestment.

• Cost synergies are to be realized within three years post-close; revenue synergies within four years.

• Synergies stem from procurement, COGS, distribution, sales, marketing, and G&A optimization.

• Revenue synergies are driven by growth in core categories and scaling in complementary geographies.

• One-time integration costs are projected at $2.5 billion over two years.